相关实验视频
Updated: Jan 9, 2026

05:20
Zebrafish Model of Neuroblastoma Metastasis
Published on: March 14, 2021
3.1K
ZNF217通过影响转移过程中的多个关键步骤来促进卵巢癌的进展
Kathryn C Wardrup1, Jessica Hoffman1, Megha J Pandya1
1Department of Biological Sciences, University of Maryland Baltimore County, Baltimore, MD, USA.
NPJ precision oncology
|December 4, 2025
概括
指蛋白217 (ZNF217) 驱动卵巢癌转移和化学抵抗. 准ZNF217可能为这种侵袭性疾病提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 卵巢癌表现出侵略性的转移和化学抵抗,导致患者的生存率低下.
- 了解这些侵略性表型的分子驱动因素对于开发有效的治疗点至关重要.
- 指蛋白217 (ZNF217) 已成为癌症进展的潜在因素.
研究的目的:
- 调查指蛋白217 (ZNF217) 在驱动卵巢癌转移,扩散和抗化学反应方面的作用.
- 为了确定ZNF217的过度表达是否与卵巢癌的不良预后相关.
- 探索ZNF217作为卵巢癌治疗点的潜力.
主要方法:
- 在卵巢癌细胞系中过度表达和耗尽ZNF217.
- 核扩散,迁移,入侵和化学抵抗的评估.
- 在小鼠模型和患者队列中分析ZNF217表达.
- 调查ZNF217的DNA结合活性及其对表皮细胞-介质细胞过渡 (EMT) 的影响.
主要成果:
- 过度表达ZNF217显著增强了卵巢癌细胞的扩散,转移和化学抵抗.
- 随着ZNF217的消耗,这些侵略性表型受到损害.
- 在临床前模型和人类患者中,ZNF217的过度表达与预后不佳有关.
- 在正常的输卵管细胞中,ZNF217诱导了转移性表型,这表明它在早期瘤进展中的作用.
- ZNF217的致癌活性依赖于其DNA结合能力和EMT的调制.
结论:
- 在卵巢癌中,ZNF217作为一种强大的瘤基因,促进了转移过程的关键步骤.
- ZNF217影响多个细胞过程,包括EMT,导致癌症的进展.
- 对于克服卵巢癌的攻击性特征,ZNF217是一个有前途的治疗标.
相关概念视频
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
NF-κB-dependent Signaling Pathway
9.7K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
9.7K
Non-Canonical Wnt Signaling Pathways
8.2K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.2K
Canonical Wnt Signaling Pathway
10.3K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.3K
Metastasis
6.3K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K

